amiodarone has been researched along with Vestibular Diseases in 2 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Vestibular Diseases: Pathological processes of the VESTIBULAR LABYRINTH which contains part of the balancing apparatus. Patients with vestibular diseases show instability and are at risk of frequent falls.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gürkov, R | 1 |
| Arbusow, V | 1 |
| Strupp, M | 1 |
| Brandt, T | 1 |
2 other studies available for amiodarone and Vestibular Diseases
| Article | Year |
|---|---|
Amiodarone-Associated Vestibulopathy.
Topics: Amiodarone; Humans; Polyneuropathies; Vestibular Diseases | 2018 |
Amiodarone-induced severe prolonged head-positional vertigo and vomiting.
Topics: Aged; Amiodarone; Humans; Male; Posture; Vertigo; Vestibular Diseases; Vomiting | 1998 |